Titomic Limited (ASX:TTT): Defence Contracts and Cold Spray Manufacturing Expansion

Aditi Sarkar

16 October 2026 10:32 PM AEDT

Titomic Limited (ASX:TTT): Defence Contracts and Cold Spray Manufacturing Expansion

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Titomic reported new United States defence, research and energy orders during September 2026.
A US$5.0 million contract covers a cold spray Manufacturing system for the US Air Force.
October updates include a Netherlands Army prototype contract and semiconductor production work.
The company is pursuing a corporate redomiciliation to the United States while intending to retain ASX quotation.
Contract delivery, production execution and transaction approvals remain important operating considerations.

Titomic Limited (ASX:TTT) develops cold spray metal manufacturing, coating and repair technologies for defence, aerospace, energy and industrial applications. Its Titomic Kinetic Fusion process deposits metal powders at high velocity without relying on conventional melting methods. Announcements during 2026 show a Business pursuing contracted equipment deliveries, specialist component work and an expanded United States operating presence.

United States Orders Add to the Contract Portfolio

In September 2026, Titomic Limited (ASX:TTT) reported a US$5.0 million (AU$6.9 million) US Air Force contract to supply, integrate and commission a high-pressure cold spray system at Tinker Air Force Base in Oklahoma. Based on its TKF 1000 platform, the project includes robotics, powder and gas management, process monitoring and quality verification. The equipment is intended for manufacturing and maintenance activities, including component repair and surface restoration.

Later in September, Titomic (ASX:TTT) announced four additional US contracts worth US$534,000 (AU$752,000). These involved coating tests, a medium-pressure TKF 623 unit, a TKF 523 unit and a deployable TKF 523 Tactical system. The company said the awards brought its US order intake over approximately four weeks to nine orders worth US$6.1 million (AU$8.7 million). These figures describe contract awards rather than Revenue already recognised.

European Work Broadens Commercial Applications

Titomic Limited (ASX:TTT) also reported European developments in October 2026. On 7 October, its Netherlands Subsidiary announced a full-rate production contract serving the semiconductor industry. The company indicated approximately EUR 0.9 million (AUD 1.5 million) of 2027 revenue at the stated production run rate. This is company-indicated future production revenue, not a completed-period financial result.

On 13 October, the company disclosed a EUR 150,000 (AUD 242,000) Netherlands Army contract to design a battlefield damage-repair prototype. The reported scope concerns prototype development, with delivery of the design scheduled for December 2026. Further testing or procurement would require separate decisions. For Titomic (ASX:TTT), such assignments illustrate the distinction between supplying established equipment and undertaking customer-specific development work.

Proposed United States Redomiciliation

The board announced plans in March 2026 to examine moving the group’s corporate domicile from Australia to the United States. In May, Titomic (ASX:TTT) entered a scheme implementation deed establishing a proposed structure under which a Delaware parent would become the holding company, subject to required approvals. The announced plan envisages retaining ASX trading through CHESS depositary interests under ticker TTT. A July update stated that work on the scheme was continuing and that the indicative timetable would be revised.

The proposed structure addresses corporate location and access to US defence-related business requirements; it should not be confused with a completed relocation or an approved US stock-market listing. Shareholder, court and other necessary approvals remain relevant to implementation. Commercial execution also depends on delivering contracted systems, meeting technical specifications and securing acceptance under customer requirements.

Key Insights

Titomic Limited (ASX:TTT) has reported contract activity across defence maintenance, energy equipment, semiconductor production and prototype development in 2026. The financial relevance of these announcements depends on order fulfilment, contract terms and recognition of revenue in future reporting periods. The proposed US redomiciliation is a separate corporate process with outstanding conditions. Together, these developments describe an industrial technology company expanding customer applications while managing execution and organisational change.

FAQs

Q: What does Titomic manufacture?

A:Titomic supplies cold spray systems and related metal coating, production and repair solutions.

Q: What was the reported US Air Force contract value?

A:The September 2026 award was US$5.0 million (AU$6.9 million).

Q: What did the October Netherlands Army contract cover?

A:It covered a EUR 150,000 (AUD 242,000) prototype design for battlefield equipment repair.

Q: Has the US redomiciliation been completed?

A:The verified company releases describe a proposed scheme subject to further steps and approvals.

Q: Do newly awarded contracts equal recognised revenue?

A:No. Revenue recognition depends on the applicable contractual performance and accounting requirements.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.